ESR1 and neoplasm: In addition, RERG has been reported to be a direct transcriptional target of ERβ1 [32], a potential tumor suppressive estrogen receptor in breast and several other cancer types [37–39], which may strengthen the estrogen inductive tumor suppressive role of RERG in breast cancer.